The Pharmaceutical Journal
Vol 277 No 7408 p41
8 July 2006

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Lord Warner endorses BNF-C

The BNF for Children, published by the Royal Pharmaceutical Society and the British Medical Association, has been praised by health minister Lord Warner in his response to a House of Lords debate this week.

Focusing on an EU Committee report on the proposed EU Regulation on paediatric medicines, the House of Lords discussed issues surrounding the pharmaceutical industry, clinical trials and the labelling of medicines.

Lord Warner said that the introduction of the BNF-C was “probably one of the most useful things I have done as a minister” and was a step taken at a national level to increase information on the paediatric use of medicines for prescribers, carers and patients.

He also said that the Government had taken steps to produce “an increase in appropriately labelled and formulated medicines for children . . . [and ensure] that appropriate standards are met for the conduct of clinical trials of medicines involving children”.